Search
Galectin Therapeutics Inc
GALTAdd to Watchlist
4.510USD
+0.180+4.16%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
297.01MMarket Cap
LossP/E TTM
Galectin Therapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-0.48
36.01%
Analyst Rating
BUY
2026-07-04
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Galectin Therapeutics Inc?
According to Galectin Therapeutics Inc's FY2025 earnings report, its current assets were 19.44M, with a year-on-year change of 12.66.
What are the total assets of Galectin Therapeutics Inc?
According to Galectin Therapeutics Inc's FY2025 earnings report, its total assets of Galectin Therapeutics Inc were 19.53M, with a year-on-year change of 11.64.
What are the total liabilities of Galectin Therapeutics Inc?
According to Galectin Therapeutics Inc's FY2025 earnings report, its total liabilities of Galectin Therapeutics Inc were 145.73M, with a year-on-year change of 20.87.
What is the total equity of Galectin Therapeutics Inc?
According to Galectin Therapeutics Inc's FY2025 earnings report, its total equity of Galectin Therapeutics Inc was -126.19M, with a year-on-year change of -22.44.
What is the net financing of Galectin Therapeutics Inc?
According to Galectin Therapeutics Inc's FY2025 earnings report, its net financing of Galectin Therapeutics Inc was 26.48M, with a year-on-year change of -15.22.
What is the Earnings Per Share (EPS) of Galectin Therapeutics Inc?
According to Galectin Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.48, with a year-on-year change of 36.01.
What is the debt-to-asset ratio of Galectin Therapeutics Inc?
According to Galectin Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 684.70, with a year-on-year change of 12.77.
What is the Return on Assets (ROA) of Galectin Therapeutics Inc?
According to Galectin Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -166.56, with a year-on-year change of 19.11.
What is the operating profit of Galectin Therapeutics Inc?
According to Galectin Therapeutics Inc's FY2025 earnings report, its operating profit was -20.09M, with a year-on-year change of 52.67.